OncLive
LightNews LightNews
banner
onclive.bsky.social
OncLive
@onclive.bsky.social
960 followers 140 following 2.7K posts
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
Posts Replies Media Videos
onclive.bsky.social
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant #lcsm #oncology www.onclive.com/view/northwe...
www.onclive.com
January 29, 2026 at 6:53 PM
onclive.bsky.social
A huge thank you to Sonali Smith, MD, of @uchicagocancer.bsky.social for stopping by for an interview covering advances in CAR T-cell therapy and the role of clinical trials in cancer care. Check out onclive.com for clips from the interview and an upcoming podcast episode! #oncology #hematology
January 29, 2026 at 5:59 PM
onclive.bsky.social
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to @fda.gov for Unresectable HCC
#oncology
www.onclive.com/view/third-n...
www.onclive.com
January 29, 2026 at 5:31 PM
onclive.bsky.social
We are excited to be on-site today at @uchicagocancer.bsky.social with some exciting interviews lined up with experts spanning topics including clinical trials, advances in CAR T-cell therapy, AI in oncology, and more! Stay tuned to onclive.com for our coverage. #oncology #AI #CART #hematology
January 29, 2026 at 3:23 PM
onclive.bsky.social
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma @andrew02114.bsky.social #mmsm www.onclive.com/view/ixazomi...
www.onclive.com
January 29, 2026 at 3:18 AM
onclive.bsky.social
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis #oncology #hematology #MPN #myelofibrosis
www.onclive.com/view/nuviser...
www.onclive.com
January 28, 2026 at 3:39 PM
onclive.bsky.social
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies #oncology #GIcancer #medtwitter @uscnorriscancer.bsky.social
www.onclive.com/view/anti-gr...
www.onclive.com
January 28, 2026 at 3:21 PM
onclive.bsky.social
BREAKING 🚨: @fda.gov Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL #lymsm #leusm
www.onclive.com/view/fda-app...
January 28, 2026 at 2:18 PM
onclive.bsky.social
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous #OvarianCancer #oncology #cancercare

www.onclive.com/view/pd-l1-e...
www.onclive.com
January 27, 2026 at 9:47 PM
onclive.bsky.social
BREAKING 🚨: @fda.gov Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma #mmsm #Oncology

Learn more 📰: onclive.com/view/fda-app...
January 27, 2026 at 7:55 PM
onclive.bsky.social
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma #oncology #RCC #RMC
www.onclive.com/view/meta-an...
www.onclive.com
January 27, 2026 at 7:14 PM
onclive.bsky.social
@foxchasecancer.bsky.social Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors
#scmsm #oncology
www.onclive.com/view/study-f...
www.onclive.com
January 27, 2026 at 6:59 PM
onclive.bsky.social
GLORA-4 Set to Evaluate Lisaftoclax Plus Azacitidine in Higher-Risk MDS in First-of-Its-Kind Study @mdanderson.bsky.social #hematology #oncology
www.onclive.com/view/glora-4...
www.onclive.com
January 27, 2026 at 1:13 PM
onclive.bsky.social
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer @stolaney1.bsky.social @danafarber.bsky.social #bcsm www.onclive.com/view/fda-app...
www.onclive.com
January 27, 2026 at 12:16 AM
onclive.bsky.social
Real-World SEER Data Highlight Age-Related Survival Gap in ICI-Treated Advanced RCC #kcsm #oncology
www.onclive.com/view/real-wo...
www.onclive.com
January 26, 2026 at 3:00 PM
onclive.bsky.social
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer #pancsm #oncology www.onclive.com/view/nalirif...
www.onclive.com
January 26, 2026 at 2:52 PM
onclive.bsky.social
Watch Pooja Phull, MD, discuss the implications of a study showing how butyrate loss may affect post-transplant outcomes in patients with multiple myeloma. And check out our site for more insights from Dr Phull! #mmsm #hematology
www.onclive.com/view/microbi...
January 23, 2026 at 11:04 PM
onclive.bsky.social
A Guide to Interviewing for Hematology/Oncology Fellowship From a Chief Fellow @weillcornell.bsky.social #oncology #oncologyfellowship
www.onclive.com/view/a-guide...
www.onclive.com
January 23, 2026 at 9:42 PM
onclive.bsky.social
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025 #oncology #FDA #bcsm #lcsm #GIcancer
www.onclive.com/view/unpacki...
www.onclive.com
January 23, 2026 at 7:37 PM
onclive.bsky.social
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma #oncology #glioblastoma
www.onclive.com/view/nogapen...
www.onclive.com
January 23, 2026 at 7:36 PM
onclive.bsky.social
Immune-Targeting Vaccine Shows Promise Intercepting Cancer in Patients With Lynch Syndrome @mdanderson.bsky.social #oncology
www.onclive.com/view/immune-...
www.onclive.com
January 23, 2026 at 4:23 PM
onclive.bsky.social
CBP/p300 Inhibition Expands Beyond Hematology Field to Show Efficacy in Solid Tumors #oncology www.onclive.com/view/cbp-p30...
www.onclive.com
January 23, 2026 at 4:12 PM
onclive.bsky.social
NALIRIFOX Remains Effective Despite Dose Modification in First-Line PDAC @mdanderson.bsky.social @weillcornell.bsky.social @mayocliniccancer.bsky.social #oncology #pancreaticcancer #PDAC
www.onclive.com/view/nalirif...
www.onclive.com
January 23, 2026 at 1:20 PM
onclive.bsky.social
GDF-15 Blockade May Deepen Neoadjuvant IO Response in Cisplatin-Ineligible MIBC @myesmo.bsky.social #blcsm #oncology www.onclive.com/view/gdf-15-...
www.onclive.com
January 22, 2026 at 8:07 PM
onclive.bsky.social
ILUSTRO Trial Signals Role for First-Line Zolbetuximab-Based Triplet for Biomarker-Selected Gastric Cancer @orlandohealth.bsky.social #oncology #gcsm
www.onclive.com/view/ilustro...
www.onclive.com
January 22, 2026 at 7:13 PM